Twist Bioscience Corporation (TWST) Net margin 2017–2025
Twist Bioscience Corporation (TWST) net profit margin by fiscal year — reported net income divided by reported revenue.
-20.6%FY2025 · since FY2017: -550.8% → -20.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -20.6% | +46.1 pp |
| FY2024 | -66.7% | +16.8 pp |
| FY2023 | -83.5% | +23.5 pp |
| FY2022 | -107.0% | +7.9 pp |
| FY2021 | -114.9% | +40.4 pp |
| FY2020 | -155.3% | +42.7 pp |
| FY2019 | -198.0% | +82.2 pp |
| FY2018 | -280.2% | +270.7 pp |
| FY2017 | -550.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TWST financial trends
TWST RevenueTWST Net incomeTWST Gross profitTWST Gross marginTWST Operating incomeTWST Operating marginTWST Operating cash flowTWST Free cash flowTWST Capital expendituresTWST Return on equityTWST Stock buybacksTWST Dividends paidTWST Total assetsTWST Total liabilitiesTWST Shareholders’ equityTWST overview →